Schett
Christoph Schett, Zell Am See AT
Patent application number | Description | Published |
---|---|---|
20140199536 | MULTILAYER COMPOSITES HAVING IMPROVED PHYSICAL PROPERTIES - The invention relates to a multi-layered composite body, comprising | 07-17-2014 |
Georg Schett, Marloffstein DE
Patent application number | Description | Published |
---|---|---|
20090098536 | Method for subgroup analysis in subjects having or being suspected of having inflammatory disease, use of anti-p38MAPK antibodies, kits and their use - The present invention relates to a method of determining whether a subject having or suspected of having inflammatory disease may potentially benefit from treatment with a p38 mitogen-activated protein kinase (p38MAPK) inhibitor, which method comprises | 04-16-2009 |
Georg Schett, Steyr AT
Patent application number | Description | Published |
---|---|---|
20130316374 | BREAST CANCER DIAGNOSTICS - The present invention relates to methods and means for detecting cancer or of predicting a patient developing cancer or of determining the rate of progression of cancer in a patient suffering from cancer, comprising determining RANKL activity and/or the amount of OPG in a sample of said patient. | 11-28-2013 |
Georg Schett, Erlangen DE
Patent application number | Description | Published |
---|---|---|
20150317796 | BRAIN FUNCTIONAL MAGNETIC RESONANCE ACTIVITY IS ASSOCIATED WITH RESPONSE TO TUMOR NECROSIS FACTOR INHIBITION - The present invention relates to a non-invasive method for predicting the responsiveness of a human subject suffering from inflammatory disease to a treatment with a therapy against said inflammatory disease using brain imaging techniques. Furthermore, the present invention relates to a pharmaceutical composition comprising an active ingredient for the treatment of human subjects suffering from inflammatory disease and being identified as responders to therapy against the inflammatory disease according to the method of the invention. Preferably, this invention relates to a non-invasive method for predicting the responsiveness of a human subject suffering from rheumatoid arthritis to a treatment with TNF-antagonists comprising at least one step of brain imaging, preferably with an fMRI apparatus. The present invention shows that response to TNFi depends on the gestalt of brain activity in rheumatoid arthritis (RA) patients. | 11-05-2015 |
Uwe Schett, Frankfurt DE
Patent application number | Description | Published |
---|---|---|
20130243966 | METHOD AND DEVICE FOR ION IMPLANTATION - In an ion implantation device and a method for the ion implantation of a substrate, a plasma having an ion density of at least 10 | 09-19-2013 |